![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 17, 2022 2:53:16 PM
I do actually do my own research and I appreciate your time. Please correct me if I am wrong. But isn’t Todos on track to operate at a loss of several million dollars this year? Their cash cow was Covid testing. That market when from a river to a stream. They haven’t replaced it yet.
Doesn’t that mean they need to issue 75,000,000 to 150,000,000 shares to cover the loss?
No where close to the 10,000,000,000 they have available. But if next year goes like this one. Slowly heading in the right direction. There could conceivably be another 300,000,000 shares issued before this ship rights itself in 2024. Especially with some big expenses that could come in for final phases of approval in 2023. Phase 3 testing for cancer and Alzheimer’s will be several million each. That is not going to be paid out of revenue. It can’t.
So we have hopefully one more struggling year and then the good times start. I understand there could be approvals in Q2 or 3. But realistically an approval probably doesn’t lead to any real money for 6 to 9 months as production, marketing, and distribution infrastructure ramps up. Which is going to require capital to do. So one last dip into the piggy bank in 2023 Q3/Q4. And then we have a real winner on our hands. Final return on investment if I cash out 2024 Q2 of maybe 2,000%.
That is the roadmap I see in my head. Which could absolutely be wrong. But that is my logic for investing in Todos.
Recent TOMDF News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/17/2023 12:29:32 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM